Independent scheme-by-scheme reviews of small REIT offers for retail investors
TL;DR Unitlens is a SEBI-registered research desk that reviews every small and medium REIT scheme before and after it lists. It covers tenants, lease expiries, fees, debt and how easily you can get out. Investors pay a yearly subscription, and it sells no units and takes nothing from the platforms it rates.
Before 2024, fractional property platforms sold office slices to individuals at ₹10–25 lakh a ticket with very little oversight, and SEBI noted these platforms had multiplied[1].
SEBI then pulled them under small and medium REIT rules - schemes of ₹50 Cr to under ₹500 Cr, at least 200 investors and a ₹10 lakh minimum each[2]. That's a big cheque for a household.
The offer documents are long, written by the people selling the units and hard to compare across seven registered managers[3]. So who tells a buyer that a scheme has one tenant whose lease ends in two years? Nobody independent does.
What it does, in regulatory terms: research analysis under SEBI's research analyst regulations. Unitlens gives no personalised advice, distributes no units and takes no fee from any REIT manager.
The seed pitched property sold as NFTs. We dropped that. Pooling public money into rent-earning property in India now falls under SEBI's REIT rules[2][4], and NFT gains face a flat 30% tax with 1% TDS[5]. The regulated route to small-ticket property already exists and what's missing is someone on the investor's side.
For each scheme Unitlens reads the offer document and filings, then publishes a plain review of tenant concentration, weighted lease expiry, rent escalations, fees at every layer, borrowing and what happens if you want to sell. Scores sit side by side across schemes and each review gets updated when quarterly results land. A free summary brings people in, and the full file and alerts are paid.
Individual investors with ₹10 lakh or more to put into property pay ₹3,000–8,000 a year (our estimate) for full reviews. Wealth managers and family offices buy a team licence. Independent advisers who have to document their research before recommending a scheme are a third buyer.
The one rule is honesty - no referral fees from managers, ever, or the whole product loses its point.
The first SM REIT registered in August 2024, and seven are on SEBI's register by October 2026[3]. SEBI last amended the REIT rules in April 2026[4]. Investors now have a regulated product with its own rules but nobody independent reading the fine print for them.
There's no public figure for the number of SM REIT investors or their total assets. Work it bottom-up instead - each scheme needs at least 200 investors at ₹10 lakh or more[2], and seven managers are registered[3]. That's a small but well-off audience.
An adjacent number is the 2,304 SEBI-registered research analysts[6], almost all of them covering listed equities.
The SM REIT managers, among them Property Share and hBits, publish their own scheme documents and marketing[3]. Personal-finance writers cover the category in general, and rating agencies rate REIT debt, not units for retail buyers.
We found no service that reviews each SM REIT scheme for investors. Our search was limited though, so check before you start.
| Difficulty | Moderate (35/100) |
| Starting capital | ₹40–80 L |
| Time to launch | 6–9 months |
The work is careful reading, not technology. Building trust is harder, because you need calls that held up over several quarters and a small audience means subscriptions grow slowly. And managers may be in no hurry to answer questions from someone who might criticise them (funny, that).
Yes. Publishing paid research on securities in India needs a SEBI licence before you charge anyone.
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't let AI publish a rating or a view on any scheme. Under SEBI's rules a registered analyst owns every call, and a model can misread a lease clause.
Want to work out the AI layer for Unitlens? Talk to Yash →
Here's what can go wrong -
I like this one for a founder with real estate finance or equity research experience who can write plainly. It is a research business that grows alongside a regulated product, and if you came for the token play then this isn't it.
Prove one thing first - that 200 investors will pay for a review of a scheme they hold or plan to buy.
Plan for roughly ₹40–80 L over 6–9 months, mostly analyst salaries, SEBI registration and building a track record.
Yes. Paid research on securities needs SEBI research analyst registration, and personalised advice falls under different rules.
Yes, wherever small-ticket property funds are sold to retail investors. Check whether your securities regulator licenses paid research before you charge for a single review.
The free Unitlens validation kit has the line-by-line capital breakdown, the effort scoring, the SEBI research rules checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for property investors, and 5 assumptions to test. Download the kit →
Thinking about building Unitlens or something close to it? The hard part is earning investors' trust while the category is still small, and I'm happy to work through that with you. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.